Furthermore, i.c.v. injection of MCLs blocked beneficial effects of (R)-ketamine on depression-like phenotypes, reduced ratio of p-CREB/CREB, reduced expression of BDNF and increased expression of MeCP2 in the mPFC of CSDS susceptible mice. Here, CREB1 is linked to depressive symptom measurement.